including COPD, emphysema, and asthma [70,71,89]. This mechanism could be exploited as a novel anti-viral therapy in combination with conventional antiviral treatments. Antiproteases, such as SLPI appear to protect the respiratory epithelium from influenza virus infection and nutritional supplements may increase the antiprotease:protease ratio. Taken together, the data shown here provide further support to the concept that targeting HA- activating proteases and decreasing oxidative stress to arrest viral infection and spread in conjunction with antiviral agents is a promising potential therapeutic intervention approach against influenza. References 1. Chowell G, Echevarria-Zuno S, Viboud C, Simonsen L, Tamerius J, et al. (2011) Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS medicine 8: e1000436. 2. Monto AS (2004) Occurrence of respiratory virus: time, place and person. The Pediatric infectious disease journal 23: S58–64. 3. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA : the journal of the American Medical Association 289: 179–186. 4. Lambert LC, Fauci AS (2010) Influenza vaccines for the future. The New England journal of medicine 363: 2036–2044. 5. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA : the journal of the American Medical Association 292: 1333–1340. 6. Kesic MJ, Simmons SO, Bauer R, Jaspers I (2011) Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free radical biology & medicine 51: 444–453. 7. Cho HY, Imani F, Miller-DeGraff L, Walters D, Melendi GA, et al. (2009) Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. American journal of respiratory and critical care medicine 179: 138–150. 8. Jakab GJ, Spannhake EW, Canning BJ, Kleeberger SR, Gilmour MI (1995) The effects of ozone on immune function. Environmental health perspectives 103 Suppl 2: 77–89. 9. Wu W, Doreswamy V, Diaz-Sanchez D, Samet JM, Kesic M, et al. (2011) GSTM1 modulation of IL-8 expression in human bronchial epithelial cells exposed to ozone. Free radical biology & medicine 51: 522–529. 10. Jakab GJ, Bassett DJ (1990) Influenza virus infection, ozone exposure, and fibrogenesis. The American review of respiratory disease 141: 1307–1315. 11. Razani-Boroujerdi S, Singh SP, Knall C, Hahn FF, Pena-Philippides JC, et al. (2004) Chronic nicotine inhibits inflammation and promotes influenza infection. Cellular immunology 230: 1–9. 12. Hernandez ML, Lay JC, Harris B, Esther CR, Jr., Brickey WJ, et al. (2010) Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone. The Journal of allergy and clinical immunology 126: 537–544 e531. 13. Garcia-Suastegui WA, Huerta-Chagoya A, Carrasco-Colin KL, Pratt MM, John K, et al. (2011) Seasonal variations in the levels of PAH-DNA adducts in young adults living in Mexico City. Mutagenesis 26: 385–391. 14. O’Neill MS, Loomis D, Borja Aburto VH, Gold D, Hertz-Picciotto I, et al. (2004) Do associations between airborne particles and daily mortality in Mexico City differ by measurement method, region, or modeling strategy? Journal of exposure analysis and environmental epidemiology 14: 429–439. 15. Borja-Aburto VH, Castillejos M, Gold DR, Bierzwinski S, Loomis D (1998) Mortality and ambient fine particles in southwest Mexico City, 1993–1995. Environmental health perspectives 106: 849–855. 16. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England journal of medicine 360: 2605–2615. 17. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557–1561. 18. Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E (2008) On the epidemiology of influenza. Virology journal 5: 29. 19. Gold DR, Damokosh AI, Pope CA, III, Dockery DW, McDonnell WF, et al. (1999) Particulate and ozone pollutant effects on the respiratory function of children in southwest Mexico City. Epidemiology 10: 8–16. 20. Torres-Jardon R, Garcia-Reynoso JA, Jazcilevich A, Ruiz-Suarez LG, Keener TC (2009) Assessment of the ozone-nitrogen oxide-volatile organic compound sensitivity of Mexico City through an indicator-based approach: measurements and numerical simulations comparison. Journal of the Air & Waste Management Association 59: 1155–1172. 21. Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, et al. (1997) Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. The Journal of biological chemistry 272: 2700–2708. 22. Schwarz KB (1996) Oxidative stress during viral infection: a review. Free radical biology & medicine 21: 641–649. Ozone Exposure on Influenza Infection Acknowledgments We thank Ms. Luisa E. Brighton for her expert technical assistance and Dr. Philip Bromberg, M.D., for his critical review of the manuscript. Author Contributions Conceived and designed the experiments: MK MM IJ. Performed the experiments: MK MM RB. Analyzed the data: MK MM RB IJ. Wrote the paper: MK. 23. Cho HY, Kleeberger SR (2010) Nrf2 protects against airway disorders. Toxicology and applied pharmacology 244: 43–56. 24. Keller JN (2006) The many nuances of oxidative stress and proteolysis. Antioxidants & redox signaling 8: 119–120. 25. Kido H, Beppu Y, Imamura Y, Chen Y, Murakami M, et al. (1999) The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses. Biopolymers 51: 79–86. 26. Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, et al. (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. The Journal of biological chemistry 267: 13573–13579. 27. Sakai K, Kawaguchi Y, Kishino Y, Kido H (1993) Electron immunohisto- chemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 41: 89–93. 28. Ying QL, Simon SR (2000) DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor. American journal of respiratory cell and molecular biology 23: 506–513. 29. Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, et al. (2001) Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. American journal of respiratory and critical care medicine 164: 886–890. 30. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, et al. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of virology 80: 9896–9898. 31. Yasuoka S, Ohnishi T, Kawano S, Tsuchihashi S, Ogawara M, et al. (1997) Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. American journal of respiratory cell and molecular biology 16: 300–308. 32. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, et al. (2010) TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. Journal of virology 84: 10016–10025. 33. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, et al. (2010) Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of virology 84: 5605–5614. 34. Bottcher-Friebertshauser E, Stein DA, Klenk HD, Garten W (2011) Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. Journal of virology 85: 1554–1562. 35. Cavarra E, Lucattelli M, Gambelli F, Bartalesi B, Fineschi S, et al. (2001) Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. American journal of physiology Lung cellular and molecular physiology 281: L412–417. 36. Szabo R, Wu Q, Dickson RB, Netzel-Arnett S, Antalis TM, et al. (2003) Type II transmembrane serine proteases. Thrombosis and haemostasis 90: 185–193. 37. Iizuka T, Ishii Y, Itoh K, Kiwamoto T, Kimura T, et al. (2005) Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes to cells : devoted to molecular & cellular mechanisms 10: 1113–1125. 38. Vogelmeier C, Biedermann T, Maier K, Mazur G, Behr J, et al. (1997) Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 10: 2114–2119. 39. Hennet T, Peterhans E, Stocker R (1992) Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. The Journal of general virology 73(Pt 1): 39–46. 40. Skrzydlewska E, Farbiszewski R, Gacko M (1997) [The effect of protein oxidation modification on protease-antiprotease balance and intracellular proteolysis]. Postepy higieny i medycyny doswiadczalnej 51: 443–456. 41. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, et al. (2011) A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of virology 85: 873–882. PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e35108